Calendar Syngene International Limited
Equities
SYNGENE
INE398R01022
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
666.20 INR | -1.54% |
|
-1.98% | -22.40% |
Mar. 11 | Syngene International to Invest Up to $56 Million in US Subsidiary | MT |
Mar. 10 | India's Syngene International acquires first US biologics facility for $36.5 mln | RE |
Chart calendar Syngene International Limited
Upcoming events on Syngene International Limited
Past events on Syngene International Limited
2025-03-12 12:30 am | Investor Meeting |
2025-02-11 05:00 am | Axis Capital India Flagship Conference - ICICI Prudential Asset Management |
2025-02-11 04:30 am | Axis Capital India Flagship Conference - Yes Securities |
2025-02-11 04:00 am | Axis Capital India Flagship Conference - B & K Securities |
2025-02-11 03:00 am | Axis Capital India Flagship Conference - Mirae Mutual Fund |
2025-02-11 01:30 am | Axis Capital India Conference - UTI Mutual Fund |
2025-02-10 11:30 pm | Axis Capital India Flagship Conference - Bandhan Mutual Fund & UBS Asset Management |
2025-01-23 07:30 am | Q3 2025 Earnings Call |
2025-01-23 04:30 am | Q3 2025 Earnings Release |
2024-12-19 05:30 am | Investor Meeting - Ventura Securities |
2024-12-18 05:30 am | Investor Meeting - Bajaj Finserv AMC |
2024-12-16 05:30 am | Investor Meeting - Stewart Investors |
2024-12-11 04:30 am | Investor Meeting - Nuvama AMC |
2024-12-11 01:30 am | Investor Meeting - Bank of America |
2024-12-06 03:30 am | Investor Meeting - Hornbill Capital |
2024-12-04 11:30 pm | Investor Meeting - Akash Ganga Investments |
2024-12-02 04:15 am | Investor Meeting - DSP Mutual Fund |
2024-11-28 01:45 am | Investor Meeting - Renaissance Investments |
2024-11-27 11:30 pm | Investor Meeting - Kotak Securities |
2024-11-25 01:30 am | Investor Meeting - SBI Life Insurance |
Past dividends on Syngene International Limited
2024-06-27 | Annual 1.25 INR |
2023-06-29 | Annual 0.5 INR |
2023-06-29 | Bonus Payment 0.75 INR |
2022-06-29 | Annual 0.5 INR |
2022-06-29 | Bonus Payment 0.5 INR |
2019-07-15 | Annual 0.5 INR |
2018-07-16 | Annual 1 INR |
2017-07-19 | Annual 1 INR |
2016-03-16 | Interim Payment 1 INR |
Annual results
Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 26 042 25 629 1.61% | 31 929 31 232 2.23% | 34 886 35 962 -2.99% | 37 039 | 42 931 | 49 862 |
EBITDA Million INR | Released Forecast Spread | 7 961 7 616 4.53% | 9 344 9 320 0.25% | 10 702 10 278 4.13% | 10 853 | 12 914 | 15 344 |
EBIT Million INR | Released Forecast Spread | 4 864 4 898 -0.7% | 5 679 5 664 0.26% | 6 443 6 271 2.74% | 6 571 | 8 000 | 10 060 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 4 844 4 874 -0.62% | 5 936 5 786 2.6% | 6 208 6 163 0.73% | 6 960 | 8 380 | 10 248 |
Net income Million INR | Released Forecast Spread | 3 958 4 032 -1.84% | 4 644 4 566 1.71% | 5 100 4 787 6.55% | 5 082 | 6 333 | 7 841 |
EPS INR | Released Forecast Spread | 9,82 10,2 -3.29% | 11,5 11,2 2.61% | 12,7 11,9 6.63% | 12,6 | 15,5 | 18,5 |
Announcement Date | 27/04/22 | 26/04/23 | 24/04/24 | - |
Quarterly results
Fiscal Period | March | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 7 681 7 134 7.66% | 7 859 7 741 1.52% | 9 944 8 991 10.6% | 8 081 7 634 5.85% | 9 101 9 144 -0.47% | 8 535 8 964 -4.79% | 9 169 10 276 -10.77% | 7 897 8 067 -2.11% | 8 963 | 9 667 | 10 395 | 9 082 | 10 514 | 11 041 |
EBITDA Million INR | Released Forecast Spread | 2 165 2 070 4.59% | 2 466 2 337 5.54% | 3 141 2 869 9.49% | 2 119 2 181 -2.86% | 2 541 2 704 -6.02% | 2 439 2 676 -8.86% | 3 269 3 122 4.69% | 1 731 2 269 -23.71% | 2 423 | 2 932 | 3 503 | |||
EBIT Million INR | Released Forecast Spread | 1 449 1 219 18.9% | 1 520 1 361 11.65% | 2 185 2 046 6.81% | 1 098 1 183 -7.22% | 1 495 1 670 -10.5% | 1 358 1 586 -14.36% | 2 158 2 090 3.26% | 662 714 -7.29% | 1 329 | 1 584 | 2 383 | 1 226 | 2 103 | 2 208 |
Net income Million INR | Released Forecast Spread | 1 020 961 6.18% | 1 097 1 134 -3.26% | 1 787 1 518 17.72% | 934 1 062 -12.05% | 1 165 1 285 -9.34% | 1 115 1 189 -6.22% | 1 886 1 559 20.95% | 757 1 053 -28.08% | 1 148 | 1 444 | ||||
EPS INR | Released Forecast Spread | 2,53 2,62 -3.51% | 2,71 2,81 -3.47% | 4,43 3,84 15.39% | 2,32 2,31 0.56% | 2,90 3,27 -11.26% | 2,77 2,95 -6.2% | 4,69 3,48 34.6% | 1,88 1,25 50.93% | 2,35 | 3,01 | 4,50 | |||
Announcement Date | 19/10/22 | 23/01/23 | 26/04/23 | 26/07/23 | 17/10/23 | 25/01/24 | 24/04/24 | 24/07/24 | - | - | - | - | - | - |
Past sector events for Syngene International Limited
2025-03-13 | POLARIS GROUP: Q4 2024 Earnings Release |
2025-03-11 | AURA BIOSCIENCES, INC.: Q4 2024 Earnings Release (Projected) |
2025-03-11 | GENSCRIPT BIOTECH CORPORATION: Q4 2024 Earnings Release |
2025-03-11 04:30 pm | OCULIS HOLDING AG: Q4 2024 Earnings Release |
2025-03-10 03:04 am | SUNMAX BIOTECHNOLOGY CO., LTD.: February 2025 Sales and Revenue Release |
2025-03-06 10:11 pm | POLARIS GROUP: February 2025 Sales and Revenue Release |
2025-03-06 04:30 pm | NUVATION BIO INC.: Q4 2024 Earnings Release |
2025-03-04 | STOKE THERAPEUTICS, INC.: Q4 2024 Earnings Release (Projected) |
2025-03-03 07:30 am | BIOHAVEN LTD.: Q4 2024 Earnings Release |
2025-03-03 07:01 am | SYNDAX PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SYNGENE Stock
- Calendar Syngene International Limited